Remarkably, some tumor types have been reported to express SST3 at similar levels or higher than SST2A (some GEP-NETs, thyroid carcinoma, thymoma, breast cancer, ovarian tumors, pheochromocytomas, and specially nonfunctioning pituitary tumors)51–60. Here, SSTR3 is linked to ovarian neoplasm.